🔗 Share this article

As America proceeds with sweeping adjustments to its vaccine recommendations, a particular individual has emerged somewhat surprisingly: Høeg, an American of Danish descent sports medicine doctor and epidemiologist who rose to prominence by casting doubt on Covid vaccines during the pandemic and has zeroed in on alleged fatalities following COVID-19 vaccination in her brief time at the US Food and Drug Administration (FDA).

Planned Changes to Pediatric Immunization Schedule

Public health authorities were set to announce radical changes to the pediatric immunization program in December, synchronizing the US with the Danish national calendar, sources say – a significant shift that would put the US out of alignment with much of the international standard with no evidence for benefit. The announcement has been delayed until the coming year.

In place of the director of the vaccine center, Dr. Høeg is listed to present at the event. She was just designated acting director of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to run the office this calendar year.

A Shift at the Regulatory Body

The acting appointment might represent a tighter collaboration between the drug and vaccine divisions as Høeg and Prasad strengthen their influence at the FDA – and it suggests a greater focus upon dismantling already-approved vaccines at the FDA.

The new acting director has often pushed for halting some childhood shot schedules in the US so as to align more like Denmark, a country with comprehensive healthcare and a number of inhabitants roughly the population of the state of Wisconsin.

So far public appearances, she has persisted in emphasizing on immunizations – usually the domain of Prasad, chief of the FDA’s vaccine center – as opposed to medication approval.

Questions Over Qualifications

Dr. Høeg has little discernible track record in medication creation, regulation or administrative roles, which has been typical for past directors of the CBER. She has worked at the FDA as a key advisor to the agency head and the vaccine center since March.

“She doesn’t seem to have the necessary background” for overseeing the CDER, said a neurologist and psychiatrist. “She’s never run a clinical trial. She lacks experience in leading a sizeable institution. She lacks background in pharmaceutical oversight.”

Past directors of CBER would “grasp laws and regulations and the underlying principles of medication creation”, said Dr. Janet Woodcock. “Frankly, she lacks the type of experience that former directors who headed the center have had.”

The drug center has an immense workload at the agency, she emphasized.

“Many people just pays attention on the novel medication approvals, but the generic program approves thousands of generic medications. There’s a biologic copycat branch, over-the-counter program and other areas, and all of those have to be looked after,” Woodcock explained. “The thing you overlook, that is precisely what that I always told people is going to bite you.”

Furthermore, a significant leadership component to the job, which supervises over 5,000 personnel. “It is a enormous leadership role, if you execute it properly,” Woodcock said.

Agency Reaction and Disputed Policies

In response to questions about Dr. Høeg's credentials and whether this selection indicates more teamwork among FDA leaders on vaccines, a spokesperson said that the “inquiries are based on flawed premises”.

“Her resume matches the duties of her position,” the official said, pointing to the time Dr. Høeg spent guiding the agency head on “medication safety and regulatory science, including computerized risk analysis and vaccine surveillance”.

As acting director, Dr. Høeg assumes responsibility for the agency head's new priority voucher program, a disputed expedited therapy clearance system that apparently concerned her former heads. “How are these therapies being selected for this fast-track system? Who is making the calls?” Howard said. “There is a lot of confidentiality happening at the FDA right now.”

Overall, he remarked, “the Food and Drug Administration seems to be moving towards laxer oversight of most medications, except for immunizations.”

Public History on Immunizations

Concerning vaccines, Dr. Høeg has a more established, if problematic, history, Howard have noted. She authored a analysis using unverified crowd-sourced reports to assess the rate of heart inflammation after Covid immunization. She counseled the state of Florida top health official Dr. Joseph Ladapo, who was said to have changed statistics to imply Covid vaccines are pose a greater threat than they are.

Included in her “wish list” for the incoming administration included revising regulations for recently developed shots and discontinuing “non-essential” immunizations, she said following the vote on a audio program. At the agency, Dr. Høeg has allegedly proposed barring adolescent males from receiving Covid vaccinations.

“She is an all-around dogmatist who begins with her preconceived notions and works backwards to fit the science in a highly misleading, fraudulent way,” Howard argued.

Consolidating Power and a “Push for Payback”

Dr. Høeg aligned with fellow dissenters, {like|